Early effects of beta-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa.
Miller, M H
In vitro studies of tircarcillin or cefsulodin combined with [3H]tobramycin were performed with Pseudomonas aeruginosa. The rate of bacterial killing, the uptake of tobramycin, and the effects on optical density were measured. Both beta-lactams increased the uptake of subinhibitory concentrations of tobramycin. This result was quantitatively associated with a 2- to 4-h time-kill potentiation and confirmed earlier studies on the mechanism of beta-lactam-aminoglycoside synergy in Escherichia coli (P. H. Plotz and B. D. Davis, Science 135:1067-1068, 1962).
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174663
- Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
- In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.
- Penetration of beta-lactams through Pseudomonas aeruginosa porin channels.
- Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate.
- In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.